First Time Loading...
H

Hua Medicine
HKEX:2552

Watchlist Manager
Hua Medicine
HKEX:2552
Watchlist
Price: 1.59 HKD -1.24% Market Closed
Updated: May 3, 2024

Hua Medicine
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hua Medicine
Operating Income Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
H
Hua Medicine
HKEX:2552
Operating Income
-¥230.1m
CAGR 3-Years
20%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Income
¥3.7B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Operating Income
¥3.3B
CAGR 3-Years
22%
CAGR 5-Years
22%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Income
¥3.6B
CAGR 3-Years
-17%
CAGR 5-Years
-3%
CAGR 10-Years
10%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Income
¥3.7B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
6%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Operating Income
¥787.7m
CAGR 3-Years
32%
CAGR 5-Years
24%
CAGR 10-Years
N/A

See Also

What is Hua Medicine's Operating Income?
Operating Income
-230.1m CNY

Based on the financial report for Dec 31, 2022, Hua Medicine's Operating Income amounts to -230.1m CNY.

What is Hua Medicine's Operating Income growth rate?
Operating Income CAGR 5Y
-10%

Over the last year, the Operating Income growth was 27%. The average annual Operating Income growth rates for Hua Medicine have been 20% over the past three years , -10% over the past five years .